1. Home
  2. FET vs PRTC Comparison

FET vs PRTC Comparison

Compare FET & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$43.79

Market Cap

493.0M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$18.67

Market Cap

464.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FET
PRTC
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.0M
464.3M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FET
PRTC
Price
$43.79
$18.67
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
173.2K
3.2K
Earning Date
02-19-2026
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$790,292,000.00
$6,391,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.75
N/A
P/E Ratio
N/A
$8.98
Revenue Growth
N/A
1265.60
52 Week Low
$12.78
$13.30
52 Week High
$45.94
$20.00

Technical Indicators

Market Signals
Indicator
FET
PRTC
Relative Strength Index (RSI) 66.17 56.32
Support Level $43.19 $17.31
Resistance Level $45.65 $19.08
Average True Range (ATR) 1.86 0.77
MACD 0.17 0.07
Stochastic Oscillator 70.33 61.77

Price Performance

Historical Comparison
FET
PRTC

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: